These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 21186827)

  • 1. Synthesis and immunogenicity of a glycopolymer conjugate.
    Lipinski T; Kitov PI; Szpacenko A; Paszkiewicz E; Bundle DR
    Bioconjug Chem; 2011 Feb; 22(2):274-81. PubMed ID: 21186827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and immunochemical studies on a Candida albicans cluster glycoconjugate vaccine.
    Wu X; Lipinski T; Carrel FR; Bailey JJ; Bundle DR
    Org Biomol Chem; 2007 Nov; 5(21):3477-85. PubMed ID: 17943207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designing a new antifungal glycoconjugate vaccine.
    Johnson MA; Bundle DR
    Chem Soc Rev; 2013 May; 42(10):4327-44. PubMed ID: 23232662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A β-mannan trisaccharide conjugate vaccine aids clearance of Candida albicans in immunocompromised rabbits.
    Lipinski T; Wu X; Sadowska J; Kreiter E; Yasui Y; Cheriaparambil S; Rennie R; Bundle DR
    Vaccine; 2012 Sep; 30(44):6263-9. PubMed ID: 22902677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of three trisaccharide congeners to investigate frame shifting of β1,2-mannan homo-oligomers in an antibody binding site.
    Costello C; Bundle DR
    Carbohydr Res; 2012 Aug; 357():7-15. PubMed ID: 22658565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of a Candida albicans disaccharide conjugate vaccine by reverse engineering a protective monoclonal antibody.
    Bundle DR; Nycholat C; Costello C; Rennie R; Lipinski T
    ACS Chem Biol; 2012 Oct; 7(10):1754-63. PubMed ID: 22877569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced immunogenicity of a tricomponent mannan tetanus toxoid conjugate vaccine targeted to dendritic cells via Dectin-1 by incorporating β-glucan.
    Lipinski T; Fitieh A; St Pierre J; Ostergaard HL; Bundle DR; Touret N
    J Immunol; 2013 Apr; 190(8):4116-28. PubMed ID: 23514738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A structurally diversified linker enhances the immune response to a small carbohydrate hapten.
    Lipinski T; Luu T; Kitov PI; Szpacenko A; Bundle DR
    Glycoconj J; 2011 May; 28(3-4):149-64. PubMed ID: 21544526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and immunochemical characterization of S-linked glycoconjugate vaccines against Candida albicans.
    Wu X; Lipinski T; Paszkiewicz E; Bundle DR
    Chemistry; 2008; 14(21):6474-82. PubMed ID: 18543264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral and cell-mediated immunity following vaccination with synthetic Candida cell wall mannan derived heptamannoside-protein conjugate: immunomodulatory properties of heptamannoside-BSA conjugate.
    Paulovičová L; Paulovičová E; Karelin AA; Tsvetkov YE; Nifantiev NE; Bystrický S
    Int Immunopharmacol; 2012 Oct; 14(2):179-87. PubMed ID: 22835427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel linker methodology for the synthesis of tailored conjugate vaccines composed of complex carbohydrate antigens and specific TH-cell peptide epitopes.
    Dziadek S; Jacques S; Bundle DR
    Chemistry; 2008; 14(19):5908-17. PubMed ID: 18478617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of a Candida albicans tetrasaccharide spanning the β1,2-mannan phosphodiester α-mannan junction.
    Dang AT; Johnson MA; Bundle DR
    Org Biomol Chem; 2012 Oct; 10(41):8348-60. PubMed ID: 22996034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Neisseria meningitidis serogroup W135 polysaccharide-tetanus toxoid conjugate vaccines made by periodate activation of O-acetylated, non-O-acetylated and chemically de-O-acetylated polysaccharide.
    Gudlavalleti SK; Lee CH; Norris SE; Paul-Satyaseela M; Vann WF; Frasch CE
    Vaccine; 2007 Nov; 25(46):7972-80. PubMed ID: 17936445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of antifungal vaccines by conjugation of β-1,2 trimannosides with T-cell peptides and covalent anchoring of neoglycopeptide to tetanus toxoid.
    Cartmell J; Paszkiewicz E; Dziadek S; Tam PH; Luu T; Sarkar S; Lipinski T; Bundle DR
    Carbohydr Res; 2015 Feb; 403():123-34. PubMed ID: 25126994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
    Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
    J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and immunogenicity of polysaccharide-protein conjugate composed of galactoglucoxylomannan of Cryptococcus laurentii.
    Bystrický S; Paulovicová E; Machová E
    FEMS Microbiol Lett; 2004 Jun; 235(2):311-4. PubMed ID: 15183879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination with mannan protects mice against systemic aspergillosis.
    Liu M; Machová E; Neščáková Z; Medovarská I; Clemons KV; Martinez M; Chen V; Bystrický S; Stevens DA
    Med Mycol; 2012 Nov; 50(8):818-28. PubMed ID: 22587733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of glycoconjugate vaccines for Candida albicans using novel linker methodology.
    Wu X; Bundle DR
    J Org Chem; 2005 Sep; 70(18):7381-8. PubMed ID: 16122263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of 3,6-branched oligomannoside fragments of the mannan from Candida albicans cell wall corresponding to the antigenic factor 4.
    Karelin AA; Tsvetkov YE; Paulovicová L; Bystrický S; Paulovicová E; Nifantiev NE
    Carbohydr Res; 2010 Jul; 345(10):1283-90. PubMed ID: 20096401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell and antibody mediated immunity induced by vaccination with novel Candida dubliniensis mannan immunogenic conjugate.
    Paulovicová E; Machová E; Tulinská J; Bystrický S
    Int Immunopharmacol; 2007 Oct; 7(10):1325-33. PubMed ID: 17673147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.